Tomorrow in Islamabad, the Pakistan–China B2B Investment Conference kicks off, bringing together over 450+ firms to forge the Sino-Pak Pharma Alliance.
With the support of DRAP, BOI, and SIFC, this summit isn’t just about discussions—it is about immediate, project-driven results. Dedicated on-site regulatory desks will be active to instantly fast-track licensing and joint venture approvals, paving the way for seamless international collaboration.
Stay tuned as we embark on this exciting new chapter for Pakistan’s pharmaceutical industry.
